Allogene Therapeutics Inc. (ALLO)

Allogene Therapeutics Inc. (ALLO $1.25)
- $1.25 Cap: $269M
- View ALLO Profile
- View Questions on ALLO

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Adaptimmune Therapeutics plc (ADAP $0.28)
- $0.28 Cap: $444M
- View ADAP Profile
- View Questions on ADAP
Allogene Therapeutics Inc. (ALLO $1.25)
- $1.25 Cap: $269M
- View ALLO Profile
- View Questions on ALLO

Q: I'm interested in investing in CAR T-Cell therapy, and these are a couple of the few I've located so far. May I have your thoughts? Are there any others you are aware of that you would prefer?

Read Answer Asked by Rick on November 10, 2021